Assessment of prescribing pattern in chronic liver disease (CLD) patients and rational use of medication in a tertiary care teaching hospital
A uni-centric prospective study
Keywords:
hepatic encephalopathy, ascites, anasarca, hepatitis C virus, PHTN, oesophageal varicesAbstract
Background: Chronic liver disease (CLD) is a condition of liver damage that includes cirrhosis and fibrosis of liver. It is a progressive destruction of liver functions due to inflammation, exertion of bile and detoxification of harmful products of metabolism. Objective : To assess the prescribing pattern in chronic liver disease patients and to facilitate rational use of medication. Method : A uni-centric prospective (observational) study was conducted for a period of 6 months for analyzing the prescribing pattern used in treating Chronic Liver Disease (CLD) patients. All the patients (both male and female) diagnosed with CLD visited to gastroenterology department were included in the study. Patients with pregnancy, age below 18 year and above 80 year were not involved in the study. Result: It was observed that the number of males accounted for the 64% of the total patients and rest 36% were females. CLD affected the age group of 48 – 58 years and the common causes were hepatitis C virus (55.55%) and alcohol consumption (26.19%).
Downloads
References
Ananda, A., Baso, Y. S., Hidayanty, H., Syarif, S., Aminuddin, A., & Bahar, B. (2022). Providing education chronic energy deficiency (CED) uses web-based she smart to improve knowledge, attitudes, and practice in adolescent girls. International Journal of Health & Medical Sciences, 5(1), 56-62. https://doi.org/10.21744/ijhms.v5n1.1833
Jain S, Upadhyaya P, Goyal J, Kumar A, Jain P, Seth V, et al. A systematic review of prescription pattern monitoring studies and their effectiveness in promoting rational use of medicines. Perspect Clin Res. 2015;6(2):86–90.
Kalaitzakis E, Simren M, Olsson R, etal.Gastrointesinal problems in patients with liver cirrhosis: associations with nutritional status and health related quality of life. Scand J Gastroenterol. 2006; 41(12): 1464–72.
Long L, Li H, Deng G, Wang X, Lu S, Li B, et al. Impact of Hepatic Encephalopathy on Clinical Characteristics and Adverse Outcomes in Prospective and Multicenter Cohorts of Patients With Acute-on-Chronic Liver Diseases. Frontiers in Medicine. 2021; 8.
Lucena Gonzalez MI, Ruiz-Ruiz J, Andrade Beilido RJ, Hidaigo-Sanchez R, Gonzalez-Correa JA, Garcia-Ruiz A, et al. The impact of hospitalization on drug prescription (in Spanish). Med Clin (Barc). 1995;104:211–215.
Lucena IM, Andrade RJ, Tognoni G, Hidalgo R, De La Cuesta F. Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis. Eur J Clin Pharmacol. 2002;58(6):435–40.
Mohammed BS, Aidoo M. Drug Treatment of Patients with Liver Cirrhosis in a Tertiary Hospital in Northern Ghana: Does It Comply with Recommended Guidelines? Uhlmann D, editor. Int J Hepatol. 2020:9750194.
Sharma A, Nagalli S. Chronic Liver Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022
Shearer MJ. Vitamin K. Lancet. 1995;345:229–234.
Shrestha R, Prajapati S. Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal. J Pharm Policy Pract [Internet]. 2019;12(1):16. Available from: https://doi.org/10.1186/s40545-019-0177-y
Sleisenger MH, Fordtran JS Gastrointestinal and liver disease. In: Feldman M, Scharschmidt BF, Sleisenger MH (eds) Gastrointestinal disease: pathophysiology, diagnosis and treatment 6th edn, vol. 2. Saunders, Philadelphia, 1998. pp 1296– 1360.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Tariq RA, Vashisht R, Sinha A, et al. Medication Dispensing Errors And Prevention. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022
Weersink RA, Burger DM, Hayward KL, Taxis K, Drenth JP, Borgsteede SD. Safe use of medication in patients with cirrhosis: pharmacokinetic and pharmacodynamic considerations. Expert Opin Drug Metab Toxicol. 2020;16(1):45–57.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
